Meperidine (Demerol): Clinical Use and Recommendations
Meperidine should generally be avoided in modern pain management due to poor efficacy, significant toxicity risks from its metabolite normeperidine, and availability of safer alternatives. 1, 2
Dosing (When Use is Unavoidable)
Per FDA labeling 3:
- Adults: 50-150 mg IM/SC every 3-4 hours
- Elderly: Use lower end of dosing range (25-50% reduction)
- IV administration: Reduce dose by 25-50%, administer slowly with diluted solution
- Maximum safe dose: ≤10 mg/kg/day for no longer than 3 days 4
- Children: 0.5-0.8 mg/lb (up to adult dose) every 3-4 hours
Critical Contraindications and Warnings
Absolute Avoidance Situations 1:
- Renal insufficiency (GFR <30 mL/min/1.73 m²) or ESRD - normeperidine accumulation causes neurotoxicity
- Concurrent serotonergic/noradrenergic medications - increased toxicity risk (SSRIs, SNRIs, MAOIs, tramadol)
- Chronic pain management - inappropriate indication 5
High-Risk Populations:
- Elderly patients: Increased confusion risk 5
- Doses >600 mg/day: 2% incidence of CNS toxic reactions 4
- Duration >3 days: Accumulation of toxic metabolite normeperidine
Monitoring Requirements
Daily evaluation is mandatory 4:
- Neurologic assessment: Monitor for tremors, myoclonus, seizures (normeperidine toxicity)
- Renal function: Check baseline and ongoing creatinine/GFR
- Medication reconciliation: Screen for serotonergic drug interactions
- Pain control adequacy: VAS scores - meperidine shows similar or inferior efficacy versus alternatives 2
- Sedation and respiratory status: Higher risk compared to other opioids 2
Clinical Context and Alternatives
The 2021 SPAQI consensus 1 explicitly recommends using the perioperative encounter to optimize pain management strategy away from meperidine given its poor efficacy profile and multiple safety concerns. A 2020 systematic review 2 of 62 randomized trials (1972-2018) found meperidine had similar or inferior analgesia compared to morphine, tramadol, fentanyl, and NSAIDs, while causing more sedation and respiratory depression.
Preferred Alternatives:
- Opioids with no active metabolites for renal patients: fentanyl, sufentanil, methadone 1
- Standard opioids: morphine, hydromorphone, oxycodone (adjust in renal dysfunction)
- Multimodal analgesia: NSAIDs/acetaminophen plus regional techniques 6
Common Pitfalls
- Suboptimal dosing regimens: 79.8% of prescriptions conflict with guidelines, often underdosed 5
- Chronic pain treatment: Meperidine is only appropriate for acute pain (≤48 hours) 5
- Ignoring renal function: Normeperidine accumulates even with normal dosing in renal impairment
- Drug interaction screening failure: Missing serotonergic medications increases toxicity risk
- Prolonged use: Risk escalates significantly after 3 days due to metabolite accumulation 4
Special Considerations
Obstetrical use 3: 50-100 mg IM/SC when labor pain becomes regular, repeated at 1-3 hour intervals - though safer alternatives exist.
Opioid-dependent patients 7: Morphine provides superior pain control versus meperidine (VAS 4.11 vs 5.85, p<0.001) and causes fewer withdrawal symptoms.
The seizure risk, while historically emphasized, may be overstated based on limited case report evidence 8, but the totality of evidence regarding poor efficacy and alternative toxicities remains compelling for avoidance.